Bioorganic and Medicinal Chemistry Letters p. 1801 - 1806 (1999)
Update date:2022-07-30
Topics:
Keenan, Richard M.
Miller, William H.
Barton, Linda S.
Bondinell, William E.
Cousins, Russell D.
Eppley, Daniel F.
Hwang, Shing-Mei
Kwon, Chet
Lago, M. Amparo
Nguyen, Thomas T.
Smith, Brian R.
Uzinskas, Irene N.
Yuan, Catherine C. K.
A peptide RGD analog containing a novel 2-aminopyridine arginine mimetic was discovered to have good affinity and selectivity for the vitronectin receptor. Incorporation of the 2-aminopyridine arginine mimetic into the 3- oxo-1,4-benzodiazepine-2-acetic acid integrin antagonist series led to novel and potent nonpeptide vitronectin receptor antagonists with promising levels of oral bioavailability.
View MoreHangZhou HuaYe Chemical Technology Co.,Ltd
Contact:+86-13505815007
Address:hangzhou
Contact:+86 512 6287 2180
Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Contact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
Jinan Decheng Hemu Medical Technology Co.，Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Chiral Quest (Suzhou) Company Ltd
website:http://www.chiralquest.com
Contact:+86-0512-62956066
Address:B1/9, 218 Xinghu Street, Suzhou Industrial Park
Doi:10.1016/j.bmc.2009.02.046
(2009)Doi:10.1021/ja01502a082
(1960)Doi:10.1246/bcsj.61.857
(1988)Doi:10.1021/ol900592b
(2009)Doi:10.1016/j.tet.2009.01.089
(2009)Doi:10.1039/b818445c
(2009)
